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1. Introduction 
Nucleotides are emerging as ubiquitous family of extracellular signaling molecules. Their 
effects are mediated through a specific class of plasma membrane receptors called 
purinergic P2 receptors that, according to the molecular structure, are further subdivided 
into two subfamilies: P2Y and P2X. Specifically, P2X receptors (P2XRs) are ligand-gated ion 
channels, whereas P2Y receptors (P2YRs) belong to the superfamily of G-protein-coupled 
receptors.  
Purinergic P2XRs are expressed in a wide range of organisms from amoeba to humans 
(Fountain et al., 2007). In mammals, seven P2X subunits (termed P2X1-7) have been found 
(North, 2002). These receptors appeared early in evolution and have a widespread 
distribution on many neurons and non-neuronal cells. The P2XRs comprise the family of 
trimeric channels that use the energy of extracellular ATP binding to initiate a depolarizing 
flux of cations, including calcium, through the pore of channels. The extracellular actions of 
ATP are terminated by ectonucleotidases, leading to the generation of ADP, a primary 
agonist for some P2YRs, and adenosine, the common agonist for adenosine subtypes of 
receptor (Ralevic and Burnstock, 1998). Substantial progress has been made in elucidating 
the roles these receptors play under physiological and pathological conditions and in our 
understanding of the functional, structural, and pharmacological properties of seven P2X 
receptor subtypes. Purinergic signaling is involved in several basic physiological responses 
such as embryonic and stem cell development, pain sensation, regulation of renal blood 
flow, inflammatory responses, auditory neurotransmission etc., whereas pathophysiology of 
purinergic signalling includes stroke, thrombosis, osteoporosis, kidney failure, bladder 
incontinence, cystic fibrosis, dry eye, cancer and brain disorders (Khakh and North, 2006; 
Surprenant and North, 2009; Burnstock, 2011). In excitable cells, P2XR activation causes an 
increase in the cytosolic Ca2+ concentration via two distinct mechanisms: by membrane 
depolarization resulting in voltage-dependent Ca2+ entry and by Ca2+ entry through the 
P2XR itself. The role of P2XR involves fast synaptic transmission mediated by ATP in both 
the peripheral (Evans et al., 1992) and central nervous systems (Edwards et al., 1992), 
modulation of neuronal excitability (Khakh and Henderson, 1998), long-term potentiation 
(Sim et al., 2006), and stimulation of hormone secretion (luteinizing hormone, prolactin, 
oxytocin and vasopressin) (Kapoor and Sladek, 2000; Stojilkovic, 2009; Stojilkovic et al., 
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2010b). ATP is also the dominant messenger for neuron-glia communication (Guthrie et al., 
1999; Newman, 2003; Fields and Burnstock, 2006).  
This review summarizes recent investigations and our contribution to the knowledge about 
the molecular structure and mechanism of function of P2X receptors, and also how do they 
facilitate neurotransmitter release in the brain and secretion of hormones in pituitary.  
2. P2X receptors 
The P2XRs are ATP-gated non-selective cation channels which are permeable to Na+, K+, 
Ca2+ and small organic cations (Valera et al., 1994; Egan and Khakh, 2004). The discovery of 
P2XRs introduced a third class of ligand-gated ion channels (North, 1996), distinct from the 
first class, represented by nicotinic acetylcholine receptors, Ǆ-aminobutyric acid (GABA) 
receptors, glycine receptors and 5-hydroxytryptamine receptors, and the second class, 
represented by glutamate receptors, ǂ-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid receptors (AMPAR) and N-methyl-D-aspartate receptors (NMDAR). In mammals, 
seven genes encode the P2XR subunits (North, 2002) which can form functional channels as 
homo- and heterotrimers (Lewis et al., 1995; Nicke et al., 1998; Stoop et al., 1999). The 
distinct P2XR subtypes are functionally differentiated by comparisons in their sensitivity to 
ATP and its analogs, antagonists and allosteric modulators. Prolonged application of ATP 
causes a decrease in the conductivity of some P2XRs, a process termed receptor 
desensitization, which is also receptor-specific (North, 2002). For P2X1R and P2X3R the rate 
of desensitization is very fast - within milliseconds, the P2X4R desensitizes within seconds. 
The P2X2R and P2X7R do not desensitize, but their pore diameter increases in the 
continuous presence of agonist (Virginio et al., 1999). Subunit P2X6 does not form functional 
homomeric channels as it is retained in the endoplasmic reticulum in the monomeric form 
(Barrera et al., 2005; Ormond et al., 2006), but its heteromeric assemblies are functional (Le et 
al., 1998; King et al., 2000). So far, three combinations of heteromeric P2X6R channels have 
been characterized in functional and biochemical studies: P2X1+P2X6 (Nicke et al., 2005), 
P2X2+P2X6 (King et al., 2000) and P2X4+P2X6 (Le et al., 1998).  
Various subclasses of P2XRs are activated with different potencies to ATP and its analogs. 
Low micromolar concentrations of ATP activate most of P2XRs, only the P2X7R requires 
millimolar concetrations of ATP. The P2X1R and P2X3R, are also potently activated by ǂǃ-
methylene ATP (ǂǃmeATP) and the P2X7R by 2’,3’-0´,3´-O-(4-benzoylbenzoyl)-ATP 
(BzATP) in micromolar range (Jacobson et al., 2002); even though BzATP is also an agonist 
for P2X1, P2X3 and P2X4 receptors. P2XRs are inhibited by pyridoxalphosphate-6-
azophenyl-2', 4'-disulfonic acid (PPADS) and suramin, which are both non-selective P2X 
antagonists (Coddou et al., 2011). Pharmacological experiments revealed two distinct 
features of P2X4R: relative resistance to suramin and PPADS (Buell et al., 1996), and robust 
sensitivity to positive modulatory effect of ivermectin, a high molecular weight lipophilic 
compound used as an antiparasitic agent in human and veterinary medicine (Burkhart, 
2000), whereas other subtypes of P2XR family are ivermectin-insensitive (Khakh et al., 1999; 
Jelinkova et al., 2006). Among P2XRs, the P2X7R is unique as it gradually develops 
permeability to organic cations, causing a sustained current growth accompanied with cell 
blebbing and death (Surprenant et al., 1996; Di Virgilio et al., 1998; Mackenzie et al., 2005; 
Adinolfi et al., 2010; Yan et al., 2010). The P2X7Rs are blocked by KN62, and reactive blue-2, 
and also by a more potent and selective antagonists N-[2-[[2-[(2–hydroxyethyl)amino]ethyl] 
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amino]-5-quinolinyl]-2-tricyclo[3.3.1.13,7]dec-1-ylacetamide dihydrochloride (AZ 10606120) 
(Michel et al., 2007) and 3-[[5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl]methyl] pyridine 
hydrochloride (A 438079) (Nelson et al., 2006).  
The P2XR subtypes are functionally differentiated also by comparisons in their calcium 
permeability which is relatively high, in the range from 2.7 % (P2X3R) to 12.4 % (P2X1R) of 
total ATP-induced current (Egan and Khakh, 2004).  
2.1 Molecular structure of P2X receptors 
Each P2XR subunit consists of a large extracellular domain which binds agonists, two -
helical transmembrane domains (TM1 and TM2) and cytoplasmic N- and C-termini (Valera 
et al., 1994; Egan et al., 2004). There are 10 conserved cysteine residues in the ectodomain 
that form five intrasubunit disulfide bonds (SS1-SS5) (Clyne et al., 2002; Ennion and Evans, 
2002; Rokic et al., 2010). Using the baculovirus-Sf9 cell expression system, the P2X2R was 
expressed and purified, and its structure was observed using electron microscopy. These 
images showed that the P2X2R protein resembles an inverted three-sided pyramid 215 Å in 
height and 200 Å in side length (Mio et al., 2005), providing visual evidence of the trimeric 
composition of the P2XR family. This shape has been in principle confirmed by 
crystalization of zebrafish P2X4.1R (Kawate et al., 2009). Crystal structure shows that 
extracellular domain of P2XR trimer, rich in beta-strands, contains three non-canonical, 
intersubunit ATP-binding sites and three major subunit-to-subunit contacts, the role of 
which is still unknown. There are no contacts between the subunits at the base of the 
extracellular domain, proximal to the TM1 and TM2 domains; these lateral fenestration are 
suggested to provide a possible pathway for ions to enter and exit the channel pore (Kracun 
et al., 2010; Kawate et al., 2011). Crystal was solved in the absence of ATP and shows 
P2X4.1R in its closed state; subunit rearrangement after ATP binding and subsequent ion 
channel opening thus remains to be elucidated. 
2.2 Role of TM2 in receptor function 
Functional studies predict that both transmembrane helices move during gating (Li et al., 
2004; Silberberg et al., 2005) and the P2XR apparently forms a parallel six-helix bundle, in 
the center of which is an aqueous cavity (Duckwitz et al., 2006; Li et al., 2011). While TM2 
plays a key role in the formation of the ion pore and selectivity filter during receptor 
activation (Rassendren et al., 1997; Egan et al., 1998; Haines et al., 2001b; Haines et al., 2001a; 
Jiang et al., 2001; Migita et al., 2001; Li et al., 2004; Khakh and Egan, 2005; Silberberg et al., 
2005; Kawate et al., 2009; Kracun et al., 2010) and is also critical as a hydrophobic anchor by 
which the receptor is fixed in the membrane (Torres et al., 1999), a contribution from TM1 to 
channel gating has also been suggested (Haines et al., 2001b; Haines et al., 2001a; Jiang et al., 
2001; Samways et al., 2008; Jindrichova et al., 2009). In particular, TM2 residues Thr336, 
Thr339 and Ser340 (P2X2R numbering) contribute to formation of the selective filter, the 
narrow region in the channel pore, (Migita et al., 2001; Egan and Khakh, 2004). Conserved 
TM2 residue Asp355 (P2X5 numbering, human receptor form) has also been shown to be 
important for this function and it initiates oligomerization of subunits in the membrane 
(Duckwitz et al., 2006). It is clear that different residues are involved in the formation of 
selectivity filter of the other P2XR subtypes because their transmembrane helices are only 
39-55% identical with the P2X2 subunit (North, 2002). For example, residues Gly340 and 
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Leu343 are important for P2X4R, in addition to Ser341 (position Thr336 in P2X2) and Ala344 
(Thr339 in P2X2) (Jelinkova et al., 2008). The gating properties of P2X channels are affected 
by alanine mutation of conserved TM2 residue Gly342 that exhibited reduced sensitivity to 
ATP in the P2X2R (Li et al., 2004) and P2X4R (Jelinkova et al., 2008). This residue has been 
suggested to play a role in helix motion as a point of local flexibility, acting like a hinge 
between the lower and the upper part of TM2 (Khakh and Egan, 2005). The region between 
P2X2R residues Gly342 and Asp349 most probably contributes to formation of the channel 
pore gate (Egan et al., 1998). As mentioned above, the P2X2 and P2X7 receptors display a 
time- and activation-dependent increase in large cation permeability (Virginio et al., 1999). 
Dilation of the pore could proceed due to channel rearrangements that occur at the interface 
between TM1 and TM2 of neighboring subunits (Jiang et al., 2003; Khakh and Egan, 2005). 
Functional studies identified three TM1 residues (Phe31, Arg33 and Gln37) and six TM2 
residues (Ile328, Ile332, Ser340, Gly342, Trp350 and Leu352) that might be involved in the 
increase of pore diameter at P2X2R (Khakh and Egan, 2005). 
2.3 Role of TM1 and molecular basis of calcium conductivity 
A study performed on several subtypes of P2X receptors revealed a key role for aromatic 
residues in the upper part of TM1 in sensitivity to agonist (Jindrichova et al., 2009). Out of 
several aromatic residues of TM1, Tyr42 (P2X4 numbering) is the only residue that is fully 
conserved among all species examined thus far (Bavan et al., 2009). Alanine or cysteine 
substitution of conserved TM1 tyrosine generated a constitutively active channel that 
exhibited enhanced ATP sensitivity in P2X2R (Haines et al., 2001a; Li et al., 2004), P2X3R 
(Jindrichova et al., 2009; Jindrichova et al., 2011) and P2X4R (Jelinkova et al., 2008; 
Jindrichova et al., 2009). This residue is important also for other receptor functions: it has 
been suggested to control Ca2+ permeability as an inter-pore binding site for Ca2+ in P2X2R 
(Samways and Egan, 2007), to link TM1 with TM2 of adjacent subunit to control P2X4R 
deactivation (Stojilkovic et al., 2010a) (Fig.1) or to stabilize desensitized states in P2X3R 
(Jindrichova et al., 2011). High Ca2+ permeability of P2X1R and P2X4R has been ascribed to 
negatively charged ectodomain residues glutamate and aspartate, localized near the 
membrane at the end of TM1 and at the beginning of TM2 (Samways and Egan, 2007). 
However, negatively charged residues are also present at the same positions in P2X3R and 
P2X7R which exhibit relatively low Ca2+ permeability (Samways and Egan, 2007) indicating 
that other residues are also involved in calcium conductivity of P2XRs. The dilatation of 
P2X2R and P2X7R channel pore is also accompanied by abnormal calcium influx.  
These properties, particularly the high throughput for Ca2+ ions, account for numerous 
physiological functions stimulated by ATP and P2XR in the central nervous system. These 
involve an increase in neuronal activity (Khakh et al., 2003), potentiation of neurotransmitter 
release (Sperlagh et al., 2007) and stimulation of hormone secretion (luteinizing hormone, 
prolactin, oxytocin and vasopressin) (Kapoor and Sladek, 2000; Stojilkovic, 2009; Stojilkovic 
et al., 2010b). 
A, Three-dimensional model and positions of the first transmembrane domains (C) and the 
second transmebrane domains (N) of the rat P2X4R as viewed from the extracellular side. 
Individual subunits are differentiated by color (gray, green and blue). The Tyr42 residue 
(red) is between TM1 and TM2 helices of adjacent subunits and its side chain is in close 
proximity to residues Ile333, I337 and Met336 (orange) from the adjacent subunit, forming a 
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network of hydrophobic interactions B, The structural model shows Tyr42 side chain 
interactions with residues in TM2 helix of neighboring subunit (blue). The distance between 
OH:Tyr42 and TM2 atoms Ile333, Ile337 and Met336 are indicated using dashed lines. The 
figure was made using PyMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre, 
Schrödinger, LLC.). 
 
Fig. 1. Homology modeling of TM domains of P2X4 receptor.  
3. Modulatory effect of P2X receptors on synaptic transmission  
Following the discovery of purinergic neurotransmission in 1972 in non-adrenergic, non-
cholinergic inhibitory nerves in guinea-pig taenia coli, ATP was identified as a co-
transmitter in both sympathetic and parasympathetic peripheral nerves and latter also in the 
central nervous systems (Burnstock, 2011). Of all tissues investigated, the mammalian brain 
has the highest levels of purines and the greatest variety of the ATP-binding P2XRs (Buell et 
al., 1996; Collo et al., 1996; Seguela et al., 1996). Both neurons and glial cells release ATP and 
express P2XRs (Fields and Stevens, 2000; Raivich, 2005; Inoue et al., 2007) and it is common 
that several subtypes of P2XRs are expressed in the plasma membrane of one cell 
(Abbracchio et al., 2009). Neurons release ATP by exocytosis together with other 
neurotransmitters, such as GABA, glycine, glutamate and noradrenaline (Jo and Schlichter, 
1999; Robertson et al., 2001; Sokolova et al., 2001; Jo and Role, 2002; Day et al., 1993). Glia 
have been shown to release ATP in response to mechanical and electrical stimulation 
(Newman, 2003; Burnstock, 2004), although the precise mechanisms have not been 
identified. The most frequent receptor forms in the brain are P2X2, P2X4, and P2X6 as well 
as heteromers composed of P2X2+X6, P2X4+X6, and perhaps P2X1+X4 receptors (Buell et al., 
1996; Collo et al., 1996). Activation of P2X receptors by extracellular ATP acts mainly as a 
short-term signal but has also several long-term effects. The short-term effects involve fast 
synaptic transmission mediated by ATP in both the peripheral (Evans et al., 1992) and 
central nervous systems (Edwards et al., 1992), modulation of neuronal excitability (Khakh 
and Henderson, 1998) and long-term potentiation (Sim et al., 2006). Long-term (trophic) role 
comprise cell proliferation, differentiation and death, growth of axons during development 
and regeneration (Heine et al., 2006; Burnstock, 2011). Like other transmitters, ATP can 
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mediate both reciprocal interactions between neurons and glia, and intercellular 
communication in astrocytic networks (Guthrie et al., 1999; Newman, 2003; Fields and 
Burnstock, 2006; Burnstock, 2007). 
3.1 Expression of P2X receptor subtypes in hypothalamus  
Purinergic P2X receptors are expressed throughout the hypothalamus where ATP, co-
released with neuropeptides, appears to be involved in the regulation of hormone secretion 
(Troadec et al., 1998; Kapoor and Sladek, 2000) and control of specific autonomic functions 
including the central mechanism of body temperature regulation (Gourine et al., 2002), for 
example. P2X2, P2X4 and P2X6, but not P2X5 receptor mRNAs have been identified in the 
rat supraoptic nucleus (SON), ventromedial nucleus, paraventricular nucleus, arcuate 
nucleus, suprachiasmatic nucleus, and several other hypothalamic areas using in situ 
hybridization; the P2X1, P2X3 and P2X7 receptors were not tested in this study (Collo et al., 
1996). Another PCR analysis revealed that P2X2, P2X3, P2X4, P2X6, and P2X7 receptor 
mRNAs are expressed in the rat SON neurons; P2X1 and P2X5 mRNAs were not found 
(Shibuya et al., 1999). In the preoptic area of the rhesus monkey, the P2X2, P2X4 and P2X7 
receptor mRNAs, but not P2X1, P2X3 and P2X5 receptor mRNAs, were identified; subunit 
P2X6 was not examined (Terasawa et al., 2005). Immunohistochemistry shows local 
differences in P2XR protein distribution in the rat hypothalamus. For example, the P2X2R 
immunoreactive neurons and nerve fibers have been found to be localized in the 
paraventricular nucleus, arcuate nucleus, retrochiasmatic area, periventricular nucleus, the 
ventral part of tuber cinereum area, supraoptic, circular, and ventral tuberomammillary 
nuclei, organum vasculosum, and median eminence (Xiang et al., 1998; Yao et al., 2003), but 
are absent in the ventromedial nucleus (Vulchanova et al., 1996; Xiang et al., 1998). The 
magnocellular neurons from paraventricular and supraoptic nuclei synthesize vasopressin 
and oxytocin and transport them to the axonal terminals in the posterior pituitary where 
they are secreted into the general circulation. Double-labeling fluorescence 
immunohistochemistry has shown that both vasopressin- and oxytocin-containing neurons 
in the SON express P2X2, P2X4 and P2X5 receptor proteins (Guo et al., 2009). P2X2R-
positive immunoreactivity has been found both on SON somata and nerve fibers (Yao et al., 
2003; Vulchanova et al., 1996; Xiang et al., 1998; Shibuya et al., 1999; Loesch and Burnstock, 
2001). Our quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis 
showed the expression of mRNAs of all P2XR subunits and several P2YRs in SON-
containing tissue; the expression of mRNAs for ionotropic P2X2R > P2X7R > P2X4R 
subunits was the most significant (Fig.2) (Vavra et al., 2011). Thus hypothalamus has a 
capacity to express both P2XR and P2YR.  
Functional studies showed that application of ATP caused an increase in Ca2+ in cultured 
hypothalamic neurons (Chen et al., 1994), acutely isolated SON neurons and glial cells 
(Shibuya et al., 1999), SON neurons in hypothalamo-neurohypophyseal system explants 
(Song et al., 2007) and rat brain slices (Vavra et al., 2011). Application of ATP also stimulates 
the release of vasopressin and oxytocin in perfused explants of the hypothalamo-
neurohypophyseal system (Gomes et al., 2009) and isolated neurohypophysial nerve 
terminals of the rat (Troadec et al., 1998). These ATP-induced effects were attenuated by the 
P2X receptor antagonists suramin and PPADS indicating that P2X2Rs or P2X3Rs play a role. 
Extracellular recordings showed that ATP application increases excitability of SON neurons 
in the hypothalamus (Day et al., 1993) and intracellular recordings from SON neurons in  
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Fig. 2. Expression and function of P2X receptors in hypothalamus.  
acute hypothalamic explants revealed that it was due to depolarization of membrane 
potential following exposure to ATP (Hiruma and Bourque, 1995). In voltage-clamped SON 
neurons of rat brain slices, application of ATP (10–100 M) stimulated inward currents that 
were potentiated by acidic pH and attenuated by PPADS suggesting the involvement of 
P2X2R (Vavra et al., 2011). Similar ATP-evoked currents were recorded from neuronal 
somata of acutely dissociated SON neurons (Shibuya et al., 1999) and isolated terminals of 
the hypothalamic neurohypophysial system (Knott et al., 2005).  
There are also evidences for the contribution of P2X4Rs, which are particularly prevalent in 
the central nervous system and hypothalamus (Illes and Ribeiro, 2004; Collo et al., 1996; 
Stojilkovic, 2009; Jo et al., 2011). Ivermectin, a receptor-specific allosteric modulator (Khakh 
et al., 1999) caused more than 2-fold augmentation of the maximum amplitude of ATP-
evoked current and prolonged the ATP-stimulated calcium responses in SON neurons of 
slices (Vavra et al., 2011). A similar potentiating effect of ivermectin has been shown 
previously in neurons from the somato-sensory cortex (Lalo et al., 2007) and pituitary 
lactorophs that endogenously express homomeric or heteromeric P2X4Rs (Zemkova et al., 
2010). The novel inhibitor of recombinant P2X4Rs, 5BDBD (Wu et al., 2011), failed to affect 
ATP-induced responses in neurons (Vavra et al., 2011), however, it may be ineffective on 
heteromeric P2X4Rs which prevail in the brain. The presence of the functional P2X2R and 
P2X4Rs on SON neurons was further corroborated by the qRT-PCR experiments, which 
demonstrated significant expression of mRNA transcripts for these receptors in SON 
tissue (Vavra et al., 2011). Significant level of mRNA for P2X7R was also observed but 
P2X1, P2X3, P2X5 and P2X6 mRNA expression levels were minor. The high mRNA level 
for P2X7 can be ascribed to P2X receptors expressed in non-neuronal cells, such as 
microglia (Collo et al., 1997), because the currents of SON neurons were not affected by 
BzATP, but non-neuronal SON cells in slices responded with an increase in intracellular 
calcium (Vavra et al., 2011).  
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ATP-evoked inward current mediated by P2X2 or P2X4 receptors, as observed in SON 
neurons, likely represents a particular example of a more general function of P2XRs: to make 
voltage-threshold more positive and to drive neurons to fire action potentials. We suppose the 
functional role of somatic P2XRs in the brain consists in controlling excitability close to the 
nominal resting potential of the neuron cell body, near − 60 mV (Vavra et al., 2011).  
A, The presence of seven P2XRs (black columns) and three P2YRs (gray columns) mRNA 
transcripts in hypothalamic tissues from 16 day-old rats. Quantitative RT-PCR analysis 
shows significant expressions of ionotropic P2X2, P2X4 and P2X7 receptor mRNAs and 
moderate levels of mRNA for P2X3, P2Y1 and P2Y2 receptors. The mRNA levels of P2 
receptor genes were related to the expression of GAPDH as a housekeeping gene 
/endogenous control. B,C Example recordings of action potentials from the SON neuron in 
slices before, during and after the application (bar) of 100 µM ATP (B) and 100 µM ADP (D). 
ATP induced depolarization and an increase in frequency of action potentials. Neither effect 
was observed after the application of ADP which had a tendency to decrease the frequency 
of action potentials. All neurons had resting membrane potential (Vm) lower than -50 mV 
when measured in current clamp mode. For details see: (Vavra et al., 2011). 
3.2 Modulation of glutamate and GABA release by presynaptic P2XRs 
ATP is viewed as a neurotransmitter in both the peripheral (Evans et al., 1992) and the 
central nervous system (Pankratov et al., 1998). It has been suggested that endogenously 
released ATP acts at postsynaptic P2XRs to mediate synaptic currents in the hippocampus 
(Edwards et al., 1992). This classical view, however, is challenged by a series of recent 
studies that showed that ATP acts rather as a modulator that stimulates the release of other 
neurotransmitters (Li et al., 1998; Sperlagh et al., 2002; Watano et al., 2004; Rodrigues et al., 
2005; Kodama et al., 2007; Sperlagh et al., 2007; Donato et al., 2008). In the SON neurons, for 
instance, all spontaneous synaptic currents were inhibited by blockers of glutamate and 
GABAA receptors and application of ATP stimulated about 2300 % increase in frequency of 
both spontaneous inhibitory and excitatory postsynaptic currents without changes in their 
amplitude (Fig.3) (Vavra et al., 2011). This finding suggests that ATP does not act as a 
spontaneously released neurotransmitter, but as a modulator that stimulates the release of 
GABA or glutamate (or both) by activating purinergic receptors in the nerve terminals 
(Vavra et al., 2011). These experiments were performed in the presence of tetrodotoxin, 
which inhibits action potentials, thus P2XRs are implicated in presynaptic function by 
stimulating Ca2+ influx into the nerve terminals. Known presynaptic P2XR subtypes with a 
role in neurotransmission include P2X1, P2X2, P2X3 and possibly P2X4 and P2X7 receptors. 
P2X1Rs have been localized and implicated in the function of sympathetic ganglion neurons 
(Calvert and Evans, 2004), cerebellum (Hervas et al., 2003) and spinal cord dorsal horn 
sensory neurons (Nakatsuka et al., 2003). Presynaptic P2X1R have been found to mediate 
agonist-evoked release of tritium-labeled glutamate from purified nerve terminals of the rat 
hippocampus (Rodrigues et al., 2005). Facilitation of both glutamate and GABA release 
mediated by presynaptic P2X1R was observed in the rat medial nucleus of the trapezoid 
body (Watano et al., 2004). Activation of presynaptic P2X1R elicits noradrenaline release 
from central catecholaminergic terminals in superfused rat hippocampal slices (Papp et al., 
2004). These receptors are present in high concentrations on some smooth muscle cells 
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(Valera et al., 1994). Another role of the P2X1R in the brain thus might be in the smooth 
muscle of small arteries and arterioles, allowing the control of blood flow and pressure. 
 
Fig. 3. Presynaptic effect of ATP on spontaneous glutamate and GABA release. 
A, ATP (100 μM) induced inward current and increase in the frequency of spontaneous 
GABAergic inhibitory postsynaptic currents (sIPSC). B, ATP induced increases in the 
frequency of spontaneous glutamatergic excitatory postsynaptic currents (sEPSC). Traces in 
an expanded time scale show spontaneous synaptic currents before (Control) and after ATP 
application (ATP). Glutamatergic and GABAergic spontaneous postsynaptic currents differ 
in their amplitudes and duration. Experiments were performed on SON neurons voltage 
clamped at -60 mV. C,D, Summary histograms showing the effect of ATP on the frequency 
(C) and amplitude (D) of sEPSCs and sIPSCs. Analysis was performed on SON neurons in 
rat brain slices. (*) P < 0.01. For details see: (Vavra et al., 2011). 
Numerous studies have shown that P2X2Rs act presynaptically to increase glutamate in 
several brain areas. Experiments with knockout mice showed that Ca2+ entry through 
presynaptic P2X2Rs increases the frequency of spontaneous AMPA receptor-mediated 
glutamatergic currents in GABAergic hippocampal interneurons (Khakh et al., 2003). 
Furthermore, inhibiting P2XRs by application of PPADS has been shown to abolish the 
glutamate-dependent postsynaptic currents evoked by focal application of ATP in dorsal 
horn neurons (Li et al., 1998 Nakatsuka and Gu, 2001). PPADS-sensitive P2X2Rs have been 
shown in glutamatergic terminals of neurons in trigeminal mesencephalic motor nucleus 
(Khakh and Henderson, 1998), the nucleus tractus solitari (Shigetomi and Kato, 2004) and 
the area postrema (Kodama et al., 2007). The presynaptic P2X2Rs have been shown to 
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underlie increase in GABA release in a subset of GABAergic interneurons in the spinal cord 
(Hugel and Schlichter, 2000) and in Purkinje cells in rat cerebellar slices (Donato et al., 2008). 
In SON neurons, the ATP-induced increases in the frequency of spontaneous excitatory and 
inhibitory postsynaptic currents were also inhibited by PPADS and potentiated by pH 6.5, 
indicating the involvement of presynaptic P2X2Rs in the release of both neurotransmitters 
(Vavra et al., 2011). 
The P2X3Rs are almost exclusively expressed in dorsal root ganglion (DRG) neuronal 
processes that are involved in acute pain (Vulchanova et al., 1997; Dunn et al., 2001; North, 
2004). Immunocytochemistry for P2X3 subunits revealed that these receptors are expressed 
in small- and medium-sized neurons but are absent from large diameter neurons 
(Vulchanova et al., 1997; Vulchanova et al., 1998; Novakovic et al., 1999). Stimulation of 
presynaptic P2XRs in DRG neuronal processes by ATP application induced glutamate 
release that activated postsynaptic glutamatergic receptors expressed in the dorsal horn 
neurons (Gu and MacDermott, 1997) and that was inhibited by PPADS. Presynaptic P2X3R 
have been also found in other brain areas, including purified nerve terminals of the rat 
hippocampus (Rodrigues et al., 2005), in cranial afferent neurons in nodose ganglia (Kato 
and Shigetomi, 2001; Jin et al., 2004), in the midbrain periaqueductal gray (Xing et al., 2008), 
in the rat medial nucleus of the trapezoid body (Watano et al., 2004). ATP-stimulated GABA 
release from rat midbrain terminals are mediated through the activation of P2X receptors 
with an abundance of P2X3 subunits (Gomez-Villafuertes et al., 2001). Activation of 
presynaptic P2X3R receptors contributes to noradrenaline release in superfused rat 
hippocampal slices (Papp et al., 2004). 
Evidence for the presence of P2X4Rs in the nerve terminals is less obvious because selective 
antagonists are lacking. We showed that the ATP-induced effect on frequency of 
spontaneous inhibitory postsynaptic currents in the SON declined during prolonged ATP 
application, which indicates the involvement of a desensitizing P2X4R (Vavra et al., 2011).  
BzATP has been reported to enhance release of glutamate by acting at P2X7Rs in purified rat 
neocortex synaptosomes (Patti et al., 2006). Possible presynaptic mechanisms underlying 
enhancement of excitatory transmitter release by P2X7R has been also suggested for 
hypoglossal motoneurons in brainstem slices (Ireland et al., 2004). However, neuronal origin of 
P2X7R is still uncertain. The P2X7Rs are expressed on satellite glial cells enwrapping the 
peripheral neurons (e.g., DRG neurons) and on microglia, astrocytes and oligodendrocytes in 
the brain. After repeated or prolonged exposure to ATP, P2X7R are able to form pores 
permeable to small molecules, and could mediate release of cytokines from satellite glial and 
microglial cells (Ferrari et al., 1997b; Ferrari et al., 1997a; Ferrari et al., 2006; Matute et al., 2007) 
or release of neurotransmitters from astrocytes. Several reports have shown that the P2X7R, 
and not other P2XRs, is responsible for IL-1ǃ release from activated myeloid cells (Mehta et al., 
2001; Le Feuvre et al., 2002). LPS-primed macrophages from transgenic mice lacking P2X7 
receptors fail to release IL-1ǃ in response to ATP, although synthesis of pro-IL-1ǃ and caspase-
1 is unaltered (Solle et al., 2001; Labasi et al., 2002). Activation of P2X7Rs has been reported to 
elicit the release of glutamate (Duan et al., 2003), GABA (Wang et al., 2002), 2-
arachidonoylglycerol (Walter et al., 2004), and purines (Ballerini et al., 1996) from cultured 
astrocytes. In neurological diseases or injuries extracellular ATP may activate P2X7Rs further 
enhancing purine release, with important pathophysiological consequences (Ballerini et al., 
1996). In paraventricular nucleus of hypothalamus, P2X7 receptor activation results in 
insertion of AMPA receptors into postsynaptic neuronal membrane (Gordon et al., 2009). 
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In the rat suprachiasmatic nuclei, ATP content and extracellular ATP levels (Yamazaki et al., 
1994; Womac et al., 2009) negatively correlate with electrical activity and arginine 
vasopressin (AVP) secretion rhythm: the frequency of action potentials and the level of AVP 
is high during the day and low during the night, but ATP release peaks during the night. 
This might indicate that ATP is primarily stored and released from distinct pool of vesicles 
and/or that ATP and AVP are released from different cells. How ATP release from 
hypothalamic cells is regulated and what is the reason for local differences in distribution of 
P2X receptor subtypes is still being elucidated. 
4. Potentiation of hormone secretion in pituitary gland 
Depolarization and Ca2+ influx stimulated by extracellular ATP has numerous functions also 
in endocrine cells. These involve stimulation of luteinizing hormone, prolactin, oxytocin and 
vasopressin hormone secretion by pituitary gland (Kapoor and Sladek, 2000; Stojilkovic, 
2009; Stojilkovic et al., 2010b). The anterior pituitary is a heterogeneous gland with multiple 
cell types that secrete six major peptide hormones necessary for reproduction, lactation, 
growth, development, metabolic homeostasis, and the response to stress: FSH and LH-
producing gonadotrophs, prolactin (PRL)-producing lactotrophs, GH-producing 
somatotrophs, TSH-producing thyrotrophs, and ACTH-producing corticotrophs. This lobe 
also contains the non-hormone-producing folliculostellate cells, which are glia-like cells, and 
endothelial cells that line the capillaries. Pituitary hormone secretion is under control of 
hypothalamic neurohormones and is also modulated by extracellular ATP (Chen et al., 1995) 
that is released by the anterior pituitary itself in a regulated manner, or coreleased with 
hypothalamic peptides (Tomic et al., 1996; Lazarowski et al., 2000; Stojilkovic and 
Koshimizu, 2001; He et al., 2005). The mRNA transcripts for several P2X subunits (P2X2R, 
P2X3R, P2X4R, and P2X7R) were identified in anterior pituitary cells from neonatal 
(Zemkova et al., 2006) and adult rats (Koshimizu et al., 2000a; Koshimizu et al., 2000b; 
Stojilkovic and Koshimizu, 2001), including two spliced forms of the P2X2R subunit. 
Experiments with the plasma membrane-targeted luciferase expressed in HEK cells or ACN 
neuroblastoma cells indicated that endogenous extracellular ATP concentrations are in the 
range of 100-200 µM, which is more than sufficient to activate all types of P2X receptors 
(Pellegatti et al., 2005). In vivo, the ATP action on gonadotroph functions could be controlled 
by ectonucleotidases 1-3, which are expressed in pituitary cells (He et al., 2005) and provide 
an effective pathway for the control of extracellular ATP concentrations. 
Detection and localization of mRNA transcripts for P2X2, P2X3 and P2X4 receptors in 
pituitary gland by in situ hybridization. PP, posterior pituitary, AP, anterior pituitary. For 
details see: (Stojilkovic et al., 2010b). 
Most anterior pituitary cells express functional P2X receptors (Fig.4) (Carew et al., 1994; 
Villalobos et al., 1997; Koshimizu et al., 2000a). The P2X2Rs were identified in pituitary 
gonadotrophs (Tomic et al., 1996; Koshimizu et al., 2000b; Zemkova et al., 2006) and 
somatotrophs (Koshimizu et al., 2000a). Lactotrophs express functional P2X4Rs (Carew et al., 
1994; He et al., 2003; Zemkova et al., 2010) as well as P2X7R subtypes (Chung et al., 2000; He 
et al., 2003). Corticotrophs seem not to respond to extracellular ATP directly by stimulation 
of any P2X receptor (Zhao et al., 2006), and identification of P2X receptors in remaining 
anterior pituitary cell type, thyrotrophs, has not yet been done. Functional studies showed 
that ATP application induces inward slowly desensitizig current and increases 
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Fig. 4. Expression of P2XR in pituitary gland.  
frequency of action potentials (Fig.5) in pituitary gonadotrophs. These responses were 
sensitive to PPADS indicating that P2X2Rs could operate as depolarizing channels in the 
pituitary (Zemkova et al., 2006). ATP could play the role of modulator in the anterior 
pituitary lactotrophs (Stojilkovic and Koshimizu, 2001), P2X4R potentiator ivermectin per se 
augmented ATP-induced prolactin secretion and slightly potentiated the effect of TRH in 
lactrotrophs which express P2X4Rs (Zemkova et al., 2006). Thus in pituitary, ATP may serve 
to synchronize of spontaneous electrical activity, to initiate intercellular Ca2+ waves, as 
observed in other cell types (Guthrie et al., 1999) and modulate G-protein coupled receptor-
stimulated Ca2+ signaling by refilling of intracellular stores from calcium influx through 
P2XR pore (Zemkova et al., 2006). Such an action of extracellular ATP could provide a 
mechanism for the amplification of the effects of hypothalamic peptides on pituitary 
hormone secretion. Further experiments should clarify to what extent these capacities of P2X 
receptors are utilized in vivo. 
www.intechopen.com
 
Facilitation of Neurotransmitter and Hormone Release by P2X Purinergic Receptors 
 
73 
 
Fig. 5. Electrophysiological characterization of the P2X2R in pituitary gonadotrophs. A, 
Gonadotrophs can be identified in a mixed population of pituitary cells because of their 
specific GnRH-induced calcium oscillations monitored as outward calcium-activated 
potassium current (IK-Ca). B, Stimulation of electrical activity by application of ATP to 
identified gonadotrophs. C, The sensitivity of ATP-induced current to suramine, general 
P2XR blocker. D, Insensitivity of ATP-induced current to ivermectin indicates that 
gonadotrophs express the P2X2 receptor. For details see: (Zemkova et al., 2006).  
5. Conclusion 
To summarize, the cellular actions of extracellular ATP and P2XRs in the brain range from 
modulation of resting membrane potential and electrical activity to stimulation of 
neurotransmitter and hormone release, including release of anterior pituitary hormones. It is 
clear that the effects of ATP and its analogs are realized by membrane depolarization 
resulting in voltage-dependent Ca2+ entry and by Ca2+ entry through the pore of P2XR itself. 
Nonetheless, the molecular and neurochemical mechanisms underlying these effects are far 
from being fully understood and likely involve multiple receptor systems and various 
signaling pathways. Experimental evidences gathered so far suggest that whereas 
neurotransmitter release seems to be linked to the activation of presynaptic P2X1, P2X2, 
P2X3 and perhaps P2X4 and P2X7 receptors expressed in nerve terminals, neuropeptide and 
hormone secretion more likely involves P2X2 and P2X4 receptors on the surface of neuronal 
somata and pituitary cells. Thus, extracellular ATP together with P2XRs comprise a new 
excitatory system in the mammalian central nervous system and an increasing number of 
studies support also an indirect role of P2XRs in inhibitory system owing to its ability to 
facilitate GABA release. However, surprisingly few studies confirmed the role of ATP as 
neurotransmitter in the central nervous system, whereas its modulatory roles are well 
established. Further studies aimed at analyzing the cellular and molecular actions of ATP in 
various brain regions and under different physiological states would be required for a 
comprehensive understanding. 
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